Deregulation of miR‐519a, 153, and 485‐5p and its clinicopathological relevance in ovarian epithelial tumours
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Kim T H, Kim Y K, Kwon Y, Heo J H, Kang H, Kim G & An H J (2010) Histopathology57, 734–743 Deregulation of miR‐519a, 153, and 485‐5p and its clinicopathological relevance in ovarian epithelial tumours Aims: The pathological and clinical significance of aberrant miRNA expression in ovarian tumours has yet to be adequately documented. The aim of this study was to assess the differences in miRNA expression of human ovarian tumours according to histological subtype, and to determine whether miRNAs are potential diagnostic and prognostic markers in ovarian cancers. Method and results: The miRNA expression profiles of 103 human ovarian tumours were evaluated. Via a bead‐based miRNA microarray, five aberrant miRNAs were selected which were expressed differentially in malignant serous tumours from borderline and benign ovarian tumours, including miRNA (miR)‐519a, miR‐18b (up‐regulation) and miR‐153, miR‐511 and miR‐485‐5p (down‐regulation). We conducted quantitative real‐time reverse transcription–polymerase chain reaction (qRT–PCR) in order to confirm that these miRNAs are differentially expressed in different histological subtypes of ovarian tumours, and compared the expression profiles of these miRNAs between different clinical subsets. The expression of these miRNAs was correlated with clinicopathological parameters. miR‐519a, miR‐153 and miR‐485‐5p were differentially expressed in four major histotypes of ovarian cancers (P < 0.05), which suggests that they might be of potential importance as diagnostic biomarkers. Down‐regulation of miR‐153 and miR‐485‐5p was correlated significantly with FIGO grade 3 (P < 0.05). Down‐regulation of miR‐153 and up‐regulation of miR‐519a were correlated significantly with advanced clinical stage (P < 0.05). The results of Kaplan–Meier survival analysis indicated that the higher expression of miR‐519a in late stage serous carcinoma was associated significantly with poor progression‐free survival (P = 0.0058). Conclusions: A significant correlation was detected between the deregulation of specific types of miRNAs, such as miR‐519a, miR‐153 and miR‐485‐5p, and clinical variables as well as histological subtypes in ovarian cancers. Hence, these miRNAs may perform functions as diagnostic or prognostic biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 1×
“High levels of miR-196a-2 expression have been found to predict poor survival in cases of pancreatic cancer,(32) and high miR-155 and low let-7a-2 expression have been correlated with poor survival in lung adenocarcinomas.(33) A recent study(34) has implicated miR-199a as a predictive marker for chemoresistant serous…”
BackgroundTumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
Cited by
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Benetatos, L., Hatzimichael, E., Londin, E., Vartholomatos, G., Loher, P., Rigoutsos, I., & Briasoulis, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1080-8 · Cited by 263
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
Wang, W., Zhao, L.-J., Tan, Y.-X., Ren, H., & Qi, Z.-T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs113 · Cited by 182
MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression
Lou, C., Xiao, M., Cheng, S., Lu, X., Jia, S., Ren, Y., & Li, Z. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.27 · Cited by 137
Huang, R.-S., Zheng, Y.-L., Li, C., Ding, C., Xu, C., & Zhao, J. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.005 · Cited by 73
Metadata
- Authors
- Kim, T. H., Kim, Y. K., Kwon, Y., Heo, J. H., Kang, H., Kim, G., & An, H. J.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2010-11
- Volume
- 57
- Issue
- 5
- Pages
- 734-743
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W1952112930
- Cited by
- 123
- References
- 5
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deregulation of miR‐519a, 153, and 485‐5p and its clinicopathological relevance in ovarian epithelial tumours. https://app.cochat.ai/papers/10.1111/j.1365-2559.2010.03686.x
- The paper
- Kim, T. H., Kim, Y. K., Kwon, Y., Heo, J. H., Kang, H., Kim, G., & An, H. J. (2010). Deregulation of miR‐519a, 153, and 485‐5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology. https://doi.org/10.1111/j.1365-2559.2010.03686.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.